This activity is designed for radiation oncologists, focusing on managing bone metastases. One of the three presentations exclusively explores stereotactic body radiation therapy (SBRT) for non-spinal bone metastases. Supporting data guides discussions on SBRT's effectiveness and strategies.
This activity is designed for radiation oncologists, focusing on managing bone metastases. One of the three presentations exclusively explores stereotactic body radiation therapy (SBRT) for non-spinal bone metastases. Supporting data guides discussions on SBRT's effectiveness and strategies.
A successful clinical practice requires more than clinical knowledge and thoughtful delivery of patient care. The current health care pressures have created a need to understand business fundamentals to advocate for best practices and a fulfilling career.
There is considerable research in preclinical and clinical domains that has investigated therapeutic interactions between radiation therapy and immunotherapies and these treatment modalities are increasingly being used in conjunction with each other.
There are many ongoing advances in clinical care in the context of palliative radiation therapy delivery, clinical decision-making on treatment options, and clinical workflows in radiotherapy delivery. Failure to stay informed leads to lower quality of care by practicing clinicians.
This article provides an overview of the current state of spatially fractionated RT (SFRT) using either GRID or LATTICE techniques. The article reviews current dosimetry, treatment planning, QA, and clinical trials.
MRI-guided Radiation Therapy (MRgRT), FLASH proton therapy, concurrent immunotherapy, and radiation therapy and SBRT for oligometastatic disease, are emerging technologies and approaches to optimize cancer care.
Given the rate of scientific advances over the past 20 years, it is difficult for practicing radiation oncologists to stay abreast of the latest drugs, their targets and mechanisms of action.
Facebook
X
LinkedIn
Forward
